What is the company's size? (Annual sales and employees)
Biologics Development Services D/B/A Immunologix Labortories's annual revenues are $10 - $100 million (see exact revenue data)
What industry is the company in?
Biologics Development Services D/B/A Immunologix Labortories is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
Biologics Development Services D/B/A Immunologix Labortories Annual Revenue and Growth Rate
Biologics Development Services D/B/A Immunologix Labortories
Note: Biologics Development Services D/B/A Immunologix Labortories's revenues are gauged from an analysis of company filings.
Biologics Development Services D/B/A Immunologix Labortories's Income Statement (based on Industry Averages)
Biologics Development Services D/B/A Immunologix Labortories P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Biologics Development Services D/B/A Immunologix Labortories is developing and marketing.
Biologics Development Services D/B/A Immunologix Labortories doesn't have any recent trademark applications, indicating Biologics Development Services D/B/A Immunologix Labortories is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IMMUNOLOGIX LABORATORIES Laboratory analysis in the field of bioanalysis to support clinical trials, veterinary science, and genetic, chemical, biotechnical and pharmaceutical industries
06/04/2018
See all trademarks and details in the Full Report.
Market Share of Biologics Development Services D/B/A Immunologix Labortories's Largest Competitors
A competitive analysis shows these companies are in the same general field as Biologics Development Services D/B/A Immunologix Labortories, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Biologics Development Services D/B/A Immunologix Labortories.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Biologics Development Services D/B/A Immunologix Labortories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
